首页> 美国卫生研究院文献>Clinical Molecular Pathology >Rare allelic imbalances but no mutations of the PRDX1 gene in human hepatocellular carcinomas
【2h】

Rare allelic imbalances but no mutations of the PRDX1 gene in human hepatocellular carcinomas

机译:罕见的等位基因失衡但在人类肝细胞癌中PRDX1基因没有突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Allelic losses on chromosome 1p are frequent in hepatocellular carcinoma (HCC), suggesting the presence of a tumour suppressor gene in this region. The gene for peroxiredoxin 1 (PRDX1), an antioxidant enzyme, has been mapped to 1p34.1. Mice lacking PRDX1 develop HCC with high frequency. Because oxidative stress has been implicated in the pathogenesis of HCC, this study was designed to determine whether the PRDX1 gene is mutated in human HCC using loss of heterozygosity (LOH) analysis, polymerase chain reaction/denaturing gradient gel electrophoresis, and DNA sequencing. LOH of at least one of four microsatellite markers within 0.8 Mb of the PRDX1 gene was seen in three of 34 informative HCCs, but no mutations or polymorphisms in the translated exons 2–6 of the PRDX1 gene were found. These results suggest that genetic alterations of the PRDX1 locus are rare events in human HCC, indicating that other genes on chromosome 1p contribute to liver carcinogenesis.
机译:1p染色体上的等位基因缺失在肝细胞癌(HCC)中很常见,表明该区域存在抑癌基因。过氧化物酶1(PRDX1)的基因,一种抗氧化酶,已定位于1p34.1。缺乏PRDX1的小鼠发生肝癌的频率很高。由于氧化应激与HCC的发病机制有关,因此本研究旨在通过杂合丢失(LOH)分析,聚合酶链反应/变性梯度凝胶电泳和DNA测序来确定PRDX1基因是否在人HCC中发生突变。在34个信息丰富的HCC中,有3个在PRDX1基因的0.8 Mb范围内至少有4个微卫星标记的LOH被发现,但在PRDX1基因的翻译外显子2-6中未发现突变或多态性。这些结果表明PRDX1基因座的遗传改变在人类HCC中是罕见的事件,表明1p号染色体上的其他基因有助于肝癌的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号